organization · Reporting owner
E&Investment, Inc.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MetaVia Inc.NRBO · Entity 7947 | 10% owner | July 26, 2022 | July 29, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MetaVia Inc.
Report date July 26, 2022 · Filed July 29, 2022
Jointly reported with E&Healthcare Investment Fund II
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectHeld by The E&Healthcare Investment Fund II | 2,890,533 |
Reported balance
After 2022-07-26 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2022-07-26 · Other · Disposed 1,445,267 · Balance 2,890,533 F1: E&Healthcare Investment Fund II distributed 1,445,267 shares to its partners on a pro rata basis, for no consideration. F2: These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by its sole general partner, E&Investment, Inc. F3: E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | Direct | 140,147 |
Reported balance
Holding disclosure · report date 2022-07-26 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 140,147 F4: E&Investment, Inc. received a pro rata distribution from E&Healthcare Investment Fund II. |
| Common StockSEC Table I · non-derivative | IndirectHeld by The E&Healthcare Investment Fund No. 6 | 1,121,190 |
Reported balance
Holding disclosure · report date 2022-07-26 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,121,190 F3: E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. F5: These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by its sole general partner, E&Investment, Inc. |
| Common StockSEC Table I · non-derivative | IndirectHeld by The E&Healthcare Investment Fund No. 7 | 1,864,799 |
Reported balance
Holding disclosure · report date 2022-07-26 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,864,799 F3: E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. F6: These shares are owned directly by The E&Healthcare Investment Fund No.7, and indirectly by its sole general partner, E&Investment, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: E&Healthcare Investment Fund II distributed 1,445,267 shares to its partners on a pro rata basis, for no consideration.
F2: These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by its sole general partner, E&Investment, Inc.
F3: E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
F4: E&Investment, Inc. received a pro rata distribution from E&Healthcare Investment Fund II.
F5: These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by its sole general partner, E&Investment, Inc.
F6: These shares are owned directly by The E&Healthcare Investment Fund No.7, and indirectly by its sole general partner, E&Investment, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 26, 2022 Filed Jul 29, 2022 01:23 UTC | MetaVia Inc. NRBO · Entity 7947 | OtherCommon Stock | 1,445,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018053 · rdgdoc.xml · nonDerivative · entry 1 E&Investment, Inc. · CIK 0001796144 · 10% owner E&Healthcare Investment Fund II · CIK 0001799534 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by The E&Healthcare Investment Fund II Disclosed balance after: 2,890,533 F1 · kind: E&Healthcare Investment Fund II distributed 1,445,267 shares to its partners on a pro rata basis, for no consideration. F2 · ownership.nature: These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by its sole general partner, E&Investment, Inc. F3 · ownership.nature: E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.